Paul Knepper, MD, PhD, Director

 Glaucoma LOCI Laboratory

Paul Knepper, MD, PhD, Director

Research Scientist

 

Research Interest:

Investigates the cause, prevention, and treatment of primary open-angle Glaucoma (POAG).

Ongoing Research:

Current investigations center on the activation of Toll-like receptor 4 (TLR4), an innate immune receptor, in primary open-angle Glaucoma.

Impact:

Prevention of degradation of high-molecular-weight hyaluronic acid by a potent hyaluronidase inhibitor, as well as inhibition of TLR4-mediated signaling, could be a novel therapy and the first therapy directly aimed at the cause of POAG.

UNIVERSITY OF ILLINOIS College of Medicine

Illinois Eye and Infirmary Logo

If you have questions, comments, or problems accessing this site, please E-mail the webmaster.

Join Mailing List

RECENT TWEETS